Viridian Therapeutics, Inc. (0K1R.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.64B |
| Enterprise Value | 2.48B |
| P/E Ratio | -7.97 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 133.2 |
| Price/Book Ratio | 6.03 |
| Enterprise/Revenue | 135.88 |
| Enterprise/EBITDA | -8.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -17.24 |
| Operating Margin | -17.81 |
| Return On Assets | -0.44 |
| Return On Equity | -0.7 |
| Revenue | 70.85M |
| Revenue/Share | 0.23 |
| Gross Profit | 69.69M |
| EBITDA | -362.24M |
| Net Income | -342.6M |
| Diluted EPS | -3.32 |
| Total Cash | 956.51M |
| Total Cash/Share | 8.42 |
| Total Debt | 243.27M |
| Total Debt/Equity | 0.42 |
| Current Ratio | 14.46 |
| Book Value Per Share | 5.12 |
| 52-Week Change | 8.88 |
| 52-Week High | 34.31 |
| 52-Week Low | 13.25 |
| Moving Average 50 Days | 22.22 |
| Moving Average 200 Days | 21.67 |
| Average Volume | 1,574 |
| Shares Outstanding | 113.56M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 21, 2021 |